In the light of growing prevalence of eye misalignment, Neurolens and Digital Vision, Inc. (DVI) have formed a collaboration to expand the prism field from 1/8th prism diopter to 1/100th prism diopter for all Neurolens designs.
This enhancement will cross all DVI platforms, including VISION Lab Management System, RxWizard™, Web-based RxWizard™ and the SEER mobile app.
Through this partnership, the companies intend to ensure that eyecare providers are able to provide a new standard of care when dealing with eye misalignment.
“This development is yet another exciting signal that the vision industry recognizes the important role that prism will play in the future of eye care,” Pierre Bertrand, Chief Executive Officer of Neurolens said in a company news release.
“At least two out of three patients experience the symptoms of eye misalignment, and this number is growing. Neurolenses provide proven relief for these patients, and we are exicted that DVI recognizes the opportunity to drive even more positive patient outcomes,” Bertrand added.
Thanks to this expanded prism range, Neurolens providers will be able to take advantage of the highly accurate measurements from the Neurolens Measurement Device, Gen 2 (NMD2) and prescribe precise prism measurements for their patients.
“We are learning more every day about how small amounts of prism can create tremendous symptom relief for patients,” says Vivek Labhishetty BSc Optometry, MSc, PhD, Director of Clinical Research for Neurolens.
With patented Contoured Prism technology, Neurolens has created the first and only prescription lenses that go beyond visual acuity to provide visual comfort for the nearly 65% of US, bringing the eyes into alignment to relieve painful symptoms.
Founded in 1983, Digital Vision, Inc. is a software consulting company specializing in optical manufacturing systems, applications, and research. Its core product is the VISION Lab Management System — a comprehensive software solution for any optical lab.